ReviewJournal of personalized medicine2024

EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis.

Isabella Michelon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.